Reference Product Identification
Reference Product Identification is a methodological process in pharmaceutical regulatory science that involves determining the appropriate comparator drug, known as the reference listed drug, for generic drug development and approval, distinguished by its role in establishing therapeutic equivalence and regulatory compliance.
23
Publications
672
Citations
146
Authors
42
Institutions
Publications per year
2017–2026
11
23
Jacqueline F. Hamilton, Alastair C. Lewis, C. Bloss et al. · Atmospheric chemistry and physics · 2003 · 63 citations · Full text
Liqi Xie, Erhui Zhang, Yan‐Peng Xu et al. · BioDrugs · 2020 · 39 citations · Full text
1–5 of 23
146
2
h-index
Advanced Bioscience Laboratories (United States), United States
2 publications · 29 citations
2
h-index
2
h-index
1
h-index
1
h-index
1–5 of 146
42
Amgen (United States)
Thousand Oaks, United States
2 h-index
13 publications
286 citations
Mediterranean Center for Environmental Studies
Valencia, Spain
2 h-index
4 publications
146 citations

University of York
York, United Kingdom
2 h-index
2 publications
73 citations

Newcastle University
Newcastle upon Tyne, United Kingdom
2 h-index
4 publications
146 citations

University of Leeds
Leeds, United Kingdom
2 h-index
8 publications
292 citations
Mercy Health
Cincinnati, United States
1 h-index
5 publications
95 citations

University of Strathclyde
Glasgow, United Kingdom
1 h-index
1 publications
28 citations
Canon (United States)
Melville, United States
1 h-index
4 publications
48 citations
1–8 of 42
3 publications · 95 citations
3
h-index
2 publications · 188 citations
2
h-index
1 publications · 14 citations
1
h-index
1 publications · 12 citations
1
h-index
AJHP · 1 publications · 17 citations
1
h-index
1–5